about
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market...
Read More
1.11
-0.02
(-1.77%)
51,498
XNAS Volume
XNAS 24 Apr, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Alzamend Neuro Inc took place on 24 Apr 2026, for the purpose of Alzamend Neuro Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Alzamend Neuro Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..